References
- Akinbami L. Asthma prevalence, health care use and mortality: United States, 2003–2005. NCHS Health E-Stats; November 2006. Available online at: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/asthma03-05/asthma03-05.htm, accessed 20 August 2009.
- Expert Panel Report III Full Report Update 2007. National Asthma Education and Prevention Program Expert Panel Report: guidelines for the diagnosis and management of asthma. Available online at: http://www.nhlbi.nih.gov/guidelines/asthma/index.htm, accessed 20 August 2009.
- Randell TL, Donaghue KC, Ambler GR, et al. Safety of the newer inhaled corticosteroids in childhood asthma. Paediatr Drugs 2003;5:481–504.
- Sorkness CA, Lemanske RF, Jr Mauger, DT, et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007;119:64–72.
- Malone R, LaForce C, et al. The safety of twice daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistant asthma. Ann Allerg Asthma Im 2005;95:66–71.
- Lenney W, Pedersen S, Boner AL, et al. Efficacy and safety of salmeterol in childhood asthma. Eur J Pediatr 1995;154:983–990.
- Bronsky EA, Pearlman DS, Pobiner BF, et al. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of two salmeterol powder delivery devices. Pediatr 1999;104:501–506.
- Morganroth J, Gussak I. Cardiac safety of noncardiac drugs. Totowa: Humana Press; 2005.
- Park MK, Guntheroth WG. Ventricular conduction disturbances. How to read pediatric ECGs. 4th ed. Philadelphia: Mosby Elsevier; 2006. p 83–95.
- Behrman RE, Kliegman RM, Jensen HB. Nelson textbook of pediatrics. 17th ed. Philadelphia: Saunders; 2004.
- Davignon A, Rautaharju P, Boisselle E, Soumis F, Megela M, Choquette A. Normal ECG standards for infants and children. Ped Cardiol 1979;1:123–131.
- Rijnbeek PR, Witsenburg E. New normal limits for the paediatric electrocardiogram. Eur Heart J 2001;22:702–711.
- Pauker SG, Kopelman RI. Clinical problem solving. How sure is sure enough? N Engl J Med 1992;326:688–691.
- GlaxoSmithKline. Prescribing Information, ADVAIR® HFA. November 2008. Available online at: www.us-gsk.com/products/assets/us_advair_hfa.pdf, accessed 4 August 2009.
- Bracamonte T, Schauer U, et al. Efficacy and safety of salmeterol/fluticasone propionate combination delivered by the Diskus® or pressurized metered dose inhaler in children with asthma. Clin Drug Invest 2005;25:1–11.
- Nair A, Menzies D, Barnes M, Burns P, McFarlane L, Lipworth B. Respirable dose delivery of fluticasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler. Brit J Clin Pharmacol 2008;66:20–26.
- American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225–244.
- Polgar G, Promadhat V. Pulmonary function testing in children, techniques and standards. Philadelphia: W.B. Saunders Co.; 1971.
- Bazett, HC. An analysis of the time relationship of electrocardiograms. Heart 1920;7:353–370.
- Fridericia, LS. Die systolendauer im elektrocardiogramm bei normalen menschen und bei herzkranken. Acta Med Scand 1920;53:469–486.
- Milic M, Bao X, Rizos D, Liu F, Ziegler MG. Literature review and pilot studies of the effect of QT correction formulas on reported β2-agonist-induced QTc prolongation. Clin Ther 2006;28:582–590.
- Gemello R, Mana F, Saitta L. Rigel: an inductive learning system. Mach Learn 1991;6:7–35.